Contents
(Unterschied zwischen Versionen)
K (→Covid19 structure) |
K (→neurology, ophthalmology, orl covid19) |
||
| Zeile 40: | Zeile 40: | ||
== neurology, ophthalmology, orl covid19 == | == neurology, ophthalmology, orl covid19 == | ||
{{tp|p=32310553|t=2020. Ophthalmic Manifestations Of Coronavirus (COVID-19)|pdf=|usr=}} | {{tp|p=32310553|t=2020. Ophthalmic Manifestations Of Coronavirus (COVID-19)|pdf=|usr=}} | ||
| + | {{tp|p=32119409|t=2020. Neuroanatomy, Nucleus Gustatory|pdf=https://www.ncbi.nlm.nih.gov/books/NBK554522/#article-36422.s6|usr=}} | ||
== Covid19 hypoxia tolerance == | == Covid19 hypoxia tolerance == | ||
Version vom 10. Mai 2020, 08:06 Uhr
the topic map of a 30 kB genome
Further reading
- search pubmed and other resources
- journal publishers collections
- ppl who want to hear your ideas on covid19
- discussion groups covid19
- PubMed selected papers unsorted to be listed in contents topics
general reviews covid19 disease
32150360 2020. Features, Evaluation and Treatment Coronavirus (COVID-19)
structure covid19
genomic variablity
Covid19 target binding and uptake
Covid19 cytopathic effects
Covid19 innate sensing
Covid19 local tissue reaction
Covid19 cytokine storm | hemophagocytic lymphohistiocytosis hlh
Covid19 ARDS
pulmonary embolism / coagulation covid19
heart covid19
32310612 2020. Cardiac Manifestations Of Coronavirus (COVID-19)
neurology, ophthalmology, orl covid19
32310553 2020. Ophthalmic Manifestations Of Coronavirus (COVID-19)
32119409 2020. Neuroanatomy, Nucleus Gustatory PDF direct
Covid19 hypoxia tolerance
Covid19 putative risk factors
Covid19 secretion
Biophysics of aerosols
Aerosolic infection prevention
Other routes of infection
Socio-psychiatric aspects of the status hygienicus
Economic aspects of the status hygienicus
Educational aspects of the status hygienicus
Safer Work and status hygienicus
jail, abattoirs... crowded indoor places...
Host, Vector, One Health aspects of Covid19
Diagnosing Covid19
anything MERS
anything SARS
anything Influenza
anything Influenza 1918
anything Ebola
Disease Models Covid19
Clinical Guidelines Covid19
Clinical Trials Covid19
Candidate Compounds Covid19
Hydroxychloroquine retarget
- check retina status known toxicity
- 91% benefit
- approval russia
- scale up production
- on safety, trial
Chlorpromazine retarget
Zinc add-on
Remdesivir retarget
Lauric acid nat. compd.
Nicotine nat. toxin
Various Leads
- 9 retargeted: ternatin4, zotatifin, plitidepsin; haloperidol, melperone, clemastine, cloperastine, pb28, progesterone
- paper in nature
hope: Vaccination Covid19
hope: Therapeutic antibodies
hope: Chemoprevention Covid19
hope: Antiviral agents Covid19
hope: Lung regeneration and repair after Covid19
hope: Neurology rehab
Remission & Recurrence
Risk group : Nursing home inmates
Tracing the Origin of Covid19
Mass Psychology of Covid19
social deprivation, suicide
